Back
Open Access

Cholesterol paradox in atrial fibrillation: is it solved in lipid-lowering drugs users?

Session: Young Investigator Award - Primary Care & Risk Factor Management
Topic: Lipids
Speaker: Mr B. Bartos (Olsztyn, PL)
Event: ESC Preventive Cardiology 2024

Congress Presentation

About the speaker

Mr Bartlomiej Bartos

SGMK Copernicus University, Olsztyn (Poland)
0 follower

4 more presentations in this session

Early insulin resistance in low-risk subjects with normal glycemia is associated with subclinical atherosclerosis

Speaker: Doctor J. Iglesies-Grau (Montreal, CA)

Access
Abstract
Slides
Video
Thumbnail

Development, validation and prospective clinical implementation of a machine learning algorithm for incident cardio-renal-metabolic diseases and cardiovascular death: the OPTIMISE study.

Speaker: Doctor R. Nadarajah (Leeds, GB)

Access
Abstract
Slides
Video
Thumbnail

Comparative effectiveness of non-pharmacological interventions on metabolic syndrome and its components: a systematic review and network meta-analysis

Speaker: Ms B. Chan (Hong Kong, HK)

Access
Abstract
Slides
Video
Thumbnail

Higher inflammatory cytokines in long-covid with cardiovascular symptoms after acute severe COVID-19? A two-year, pre-vaccine, longitudinal, exploratory, nested cohort.

Speaker: Doctor C. Luz Goulart (Manaus, BR)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Young Investigator Award - Primary Care & Risk Factor Management

Speakers: Mr B. Bartos, Doctor J. Iglesies-Grau, Doctor R. Nadarajah, Ms B. Chan, Doctor C. Luz Goulart
Access
Thumbnail

About the event

Image

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb